Nature Communications (Oct 2022)
Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
Abstract
Profiling antibody repertoires using proteomic approaches may provide a way of screening for antibody cross-reactivity against SARS-CoV-2 variants. Here the authors use a IgG1 specific cleavage method to analyse the IgG1 repertoire within recovered patients and relate this to antibody binding and neutralisation.